A century of Melbourne-made health innovation

As Australia’s only independent medical research institute dedicated to improving health outcomes for people living with heart attack, heart failure, diabetes and obesity, Baker Institute is helping reshape what it means to prevent, manage and live with chronic disease.

Its work spans discovery science, clinical trials and community health initiatives, translating breakthroughs into real-world public health impact.

Shaping a legacy

Founded in Prahran in 1926 with a small team, the Institute is now home to more than 600 staff, students and collaborators at Melbourne’s Alfred Research Alliance precinct.

With deep roots in Melbourne and a global outlook, it works alongside academic partners including the universities of Cambridge, Oxford, Melbourne, Monash, La Trobe and Deakin, as well as Steno Diabetes Centre Copenhagen, towards a shared goal: delivering better health sooner.

Beyond the laboratory, the Institute’s clinics and education programs support patients and GPs to manage and prevent chronic conditions today. This includes one of the largest diabetes clinics in the Southern Hemisphere, located here in Melbourne.

The past year reflects the scale of the Institute’s contribution to healthcare. Nearly 150 clinical trials are underway, while a $6.5 million philanthropic investment is supporting the development of an mRNA-based vaccine aimed at preventing heart attacks.

In partnership with the University of Oxford, the Institute has also established Australia’s first cardiometabolic imaging facility, designed to help clinicians better understand and treat the heart under stress.

Other work includes trialling new technology for people with diabetes and advancing research into regenerating insulin in pancreatic stem cells, with the long-term aim of reducing the need for regular injections.

Renewed leadership into the next century

Dr Jackie Fairley has commenced as Chair, bringing extensive biotechnology and pharmaceutical experience as well as a personal connection to the Institute’s legacy of women in science. Cardiologist and researcher Professor John Greenwood, who joined from the United Kingdom in 2023, is leading the organisation’s vision as Director. A refreshed brand identity further signals an Institute looking ahead to the future of heart and diabetes care.

Much has changed over 100 years, but the Institute’s purpose remains constant: helping people live healthier, longer lives.

Its century of Melbourne-made innovation demonstrates the important role Committee for Melbourne members play in strengthening the city’s global reputation for research, collaboration and impact.

Connect with Baker Heart and Diabetes Institute

Get in touch with Manager, Strategic Relationships Sarah Cleveland at Sarah.Cleveland@baker.edu.au for enquiries on how to:

• Partner with the Institute on initiatives that improve community health outcomes and address cardiovascular disease, diabetes and obesity.
• Contribute expertise, networks and ideas across business, industry, education, sport, technology and community sectors.
• Help the Institute reach new audiences and communities, extending research impact beyond the laboratory and into workplaces, homes and everyday life.
• Start a conversation about innovation, community programs, thought leadership or partnership opportunities.